[{"id":"a23f867a-7906-432e-89da-e08a603a14c4","acronym":"","url":"https://clinicaltrials.gov/study/NCT01938638","created_at":"2021-01-18T08:46:22.936Z","updated_at":"2025-02-25T17:07:03.748Z","phase":"Phase 1","brief_title":"Open Label Phase I Dose Escalation Study With BAY1143572 in Patients With Advanced Cancer","source_id_and_acronym":"NCT01938638","lead_sponsor":"Bayer","biomarkers":" MYC • PCNA","pipe":" | ","alterations":" MYC expression • PCNA expression","tags":["MYC • PCNA"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MYC expression • PCNA expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e atuveciclib (BAY 1143572)"],"overall_status":"Completed","enrollment":" Enrollment 80","initiation":"Initiation: 09/26/2013","start_date":" 09/26/2013","primary_txt":" Primary completion: 08/17/2016","primary_completion_date":" 08/17/2016","study_txt":" Completion: 09/19/2016","study_completion_date":" 09/19/2016","last_update_posted":"2017-10-20"}]